These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 1798703)
1. Site-directed mutagenesis on TEM-1 beta-lactamase: role of Glu166 in catalysis and substrate binding. Delaire M; Lenfant F; Labia R; Masson JM Protein Eng; 1991 Oct; 4(7):805-10. PubMed ID: 1798703 [TBL] [Abstract][Full Text] [Related]
2. A triple mutant in the Ω-loop of TEM-1 β-lactamase changes the substrate profile via a large conformational change and an altered general base for catalysis. Stojanoski V; Chow DC; Hu L; Sankaran B; Gilbert HF; Prasad BV; Palzkill T J Biol Chem; 2015 Apr; 290(16):10382-94. PubMed ID: 25713062 [TBL] [Abstract][Full Text] [Related]
3. Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase. Petrosino JF; Palzkill T J Bacteriol; 1996 Apr; 178(7):1821-8. PubMed ID: 8606154 [TBL] [Abstract][Full Text] [Related]
4. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics. Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768 [TBL] [Abstract][Full Text] [Related]
5. Multiple substitutions at position 104 of beta-lactamase TEM-1: assessing the role of this residue in substrate specificity. Petit A; Maveyraud L; Lenfant F; Samama JP; Labia R; Masson JM Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):33-40. PubMed ID: 7826350 [TBL] [Abstract][Full Text] [Related]
6. Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitors. Madec S; Blin C; Krishnamoorthy R; Picard B; Chaibi el B; Fouchereau-Péron M; Labia R FEMS Microbiol Lett; 2002 May; 211(1):13-6. PubMed ID: 12052544 [TBL] [Abstract][Full Text] [Related]
7. Catalytic mechanism of active-site serine beta-lactamases: role of the conserved hydroxy group of the Lys-Thr(Ser)-Gly triad. Dubus A; Wilkin JM; Raquet X; Normark S; Frère JM Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):485-94. PubMed ID: 8042993 [TBL] [Abstract][Full Text] [Related]
8. Mutagenesis of amino acid residues in the SHV-1 beta-lactamase: the premier role of Gly238Ser in penicillin and cephalosporin resistance. Hujer AM; Hujer KM; Bonomo RA Biochim Biophys Acta; 2001 May; 1547(1):37-50. PubMed ID: 11343789 [TBL] [Abstract][Full Text] [Related]
9. Structures of ceftazidime and its transition-state analogue in complex with AmpC beta-lactamase: implications for resistance mutations and inhibitor design. Powers RA; Caselli E; Focia PJ; Prati F; Shoichet BK Biochemistry; 2001 Aug; 40(31):9207-14. PubMed ID: 11478888 [TBL] [Abstract][Full Text] [Related]
10. Site-saturation mutagenesis and three-dimensional modelling of ROB-1 define a substrate binding role of Ser130 in class A beta-lactamases. Juteau JM; Billings E; Knox JR; Levesque RC Protein Eng; 1992 Oct; 5(7):693-701. PubMed ID: 1480622 [TBL] [Abstract][Full Text] [Related]
11. Neutron diffraction studies of a class A beta-lactamase Toho-1 E166A/R274N/R276N triple mutant. Tomanicek SJ; Blakeley MP; Cooper J; Chen Y; Afonine PV; Coates L J Mol Biol; 2010 Mar; 396(4):1070-80. PubMed ID: 20036259 [TBL] [Abstract][Full Text] [Related]
12. Engineering a novel beta-lactamase by a single point mutation. Jacob F; Joris B; Dideberg O; Dusart J; Ghuysen JM; Frère JM Protein Eng; 1990 Oct; 4(1):79-86. PubMed ID: 2127105 [TBL] [Abstract][Full Text] [Related]
13. Site-directed mutagenesis at the active site of Escherichia coli TEM-1 beta-lactamase. Suicide inhibitor-resistant mutants reveal the role of arginine 244 and methionine 69 in catalysis. Delaire M; Labia R; Samama JP; Masson JM J Biol Chem; 1992 Oct; 267(29):20600-6. PubMed ID: 1400382 [TBL] [Abstract][Full Text] [Related]
14. Role of the omega-loop in the activity, substrate specificity, and structure of class A beta-lactamase. Banerjee S; Pieper U; Kapadia G; Pannell LK; Herzberg O Biochemistry; 1998 Mar; 37(10):3286-96. PubMed ID: 9521648 [TBL] [Abstract][Full Text] [Related]
15. Site-directed mutagenesis of beta-lactamase TEM-1. Investigating the potential role of specific residues on the activity of Pseudomonas-specific enzymes. Lenfant F; Petit A; Labia R; Maveyraud L; Samama JP; Masson JM Eur J Biochem; 1993 Nov; 217(3):939-46. PubMed ID: 8223651 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of AmpC beta-lactamase through a destabilizing interaction in the active site. Trehan I; Beadle BM; Shoichet BK Biochemistry; 2001 Jul; 40(27):7992-9. PubMed ID: 11434768 [TBL] [Abstract][Full Text] [Related]
18. Probing the active site of beta-lactamase R-TEM1 by informational suppression. Lenfant F; Labia R; Masson JM Biochimie; 1990; 72(6-7):495-503. PubMed ID: 2124150 [TBL] [Abstract][Full Text] [Related]
19. Effects on substrate profile by mutational substitutions at positions 164 and 179 of the class A TEM(pUC19) beta-lactamase from Escherichia coli. Vakulenko SB; Taibi-Tronche P; Tóth M; Massova I; Lerner SA; Mobashery S J Biol Chem; 1999 Aug; 274(33):23052-60. PubMed ID: 10438473 [TBL] [Abstract][Full Text] [Related]
20. Selection strategy for site-directed mutagenesis based on altered beta-lactamase specificity. Andrews CA; Lesley SA Biotechniques; 1998 Jun; 24(6):972-4, 976, 978 passim. PubMed ID: 9631188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]